Literature DB >> 23115652

Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal.

Rahul Pradhan1, Umesh Shrestha, Samir C Gautam, Stephen Thorson, Kabindra Shrestha, Bharat K Yadav, Dominic F Kelly, Neelam Adhikari, Andrew J Pollard, David R Murdoch.   

Abstract

BACKGROUND: There are limited data on the etiology and characteristics of bloodstream infections in children presenting in hospital outpatient settings in South Asia. Previous studies in Nepal have highlighted the importance of murine typhus as a cause of febrile illness in adults and enteric fever as a leading bacterial cause of fever among children admitted to hospital.
METHODS: We prospectively studied a total of 1084 febrile children aged between 2 months and 14 years presenting to a general hospital outpatient department in Kathmandu Valley, Nepal, over two study periods (summer and winter). Blood from all patients was tested by conventional culture and by real-time PCR for Rickettsia typhi.
RESULTS: Putative etiological agents for fever were identified in 164 (15%) patients. Salmonella enterica serovar Typhi (S. Typhi) was identified in 107 (10%), S. enterica serovar Paratyphi A (S. Paratyphi) in 30 (3%), Streptococcus pneumoniae in 6 (0.6%), S. enterica serovar Typhimurium in 2 (0.2%), Haemophilus influenzae type b in 1 (0.1%), and Escherichia coli in 1 (0.1%) patient. S. Typhi was the most common organism isolated from blood during both summer and winter. Twenty-two (2%) patients were PCR positive for R. typhi. No significant demographic, clinical and laboratory features distinguished culture positive enteric fever and murine typhus.
CONCLUSIONS: Salmonella infections are the leading cause of bloodstream infection among pediatric outpatients with fever in Kathmandu Valley. Extension of immunization programs against invasive bacterial disease to include the agents of enteric fever and pneumococcus could improve the health of children in Nepal.

Entities:  

Mesh:

Year:  2012        PMID: 23115652      PMCID: PMC3480362          DOI: 10.1371/journal.pone.0047531

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Although febrile illness is one of the most common reasons for seeking medical care in Nepal, information on the clinical importance of invasive bacterial infections is often unavailable due to limited diagnostic microbiological facilities. This is especially true of patients who present to hospital outpatient departments and do not need admission, as these patients are rarely investigated. We have previously shown that vaccine-preventable bacterial infections are important causes of hospitalization in Nepali children [1], [2]. In particular, there is a high burden of enteric (typhoid) fever, which has also been demonstrated in adults [3], [4]. However, the spectrum and burden of invasive bacterial infections among children seen in outpatient clinics remain poorly defined. The hospital outpatient clinic functions as a primary care facility in urban Nepal and it is in this setting that the majority of pediatric febrile illness is managed. The importance of Rickettsia typhi as a cause of febrile illness in South Asia has been increasingly appreciated [3], [4], [5], [6], but there are limited data from pediatric studies. Recently, relatively high rate of murine typhus was reported among febrile adults in Nepal [7], and serological studies performed in various countries outside the region highlight the importance of this disease in children [8], [9], [10], [11]. We describe the etiology and burden of bloodstream infections and murine typhus in febrile children presenting to the pediatric outpatient department of a large district general hospital in Kathmandu Valley, Nepal. In order to address seasonal variations, the study was conducted over two study periods during summer and winter.

Materials and Methods

Setting

Nepal is a low income country with an under five year old mortality rate of 50/1000 live births [12]. Kathmandu Valley, the main urban center of Nepal with three districts, has a population of 2.1 million (average population density: 2372/km2) of which 29% are under 15 years of age [13]. Situated at an average altitude of 1616 m, the Valley has a sub-tropical cool temperate climate with a hot summer/monsoon season (June to September; average maximum temperature 29°C; rainfall 1200 mm/year) and cool, dry winters (December to February; average minimum temperature 2°C). Overcrowding, insufficient water supply, inadequate sanitation, and pollution are significant problems in Kathmandu Valley. In summer there is a heavy burden of water-borne diseases and in winter respiratory tract infections are predominant. Enteric fever is endemic in the city. At the time of the study, Patan Hospital was one of only two large hospitals in Kathmandu Valley with a sizeable pediatric department. Patan Hospital accepts patients from all over the Valley. Annually the Pediatric Department cares for over 50,000 outpatients (21% of all hospital outpatient attendances) and accepts approximately 2,700 inpatient admissions. Only 10% of the patients reside outside Kathmandu Valley. During the study period, pneumococcal conjugate vaccines were not available in the country. Vaccines against Haemophilus influenzae type b and typhoid were available within the private market, but they were not widely used.

Patients

To capture the seasonal spectrum of infectious diseases, the study was conducted during two periods. The summer study took place between April 30 and August 22, 2006, and the winter study between December 15, 2006, and February 27, 2007. Consecutive children between 2 months and 14 years of age presenting to our hospital outpatient clinics with axillary temperature of ≥38°C (recorded in the clinic at the time of presentation) were offered enrollment in the study. Written informed consent was obtained from parents or caregivers of all patients included in the study. Any patient who was hospitalized within 24 hours after their outpatient visit was excluded. Data were recorded on case report forms and then computerized. Irrespective of severity of disease, blood was drawn from all patients for blood culture, complete blood count and Rickettsia typhi PCR. Other tests were performed as indicated by the patient’s clinical condition. The case report forms and laboratory results for all patients were reviewed by one of two senior pediatricians, and a final diagnosis was assigned.

Laboratory Methods

Blood samples were inoculated into BACTEC™ PEDS PLUS™/F blood culture bottles (Becton Dickinson, USA), incubated at 35°C and processed manually. All bottles were checked twice daily for turbidity and had subcultures performed, irrespective of turbidity, at 12–24 hours and after five days of incubation. Bacterial identification was done by standard microbiological methods and antibiotic susceptibility testing was by disc diffusion using Clinical and Laboratory Standards Institute guidelines [14]. Isolates were sent to Canterbury Health Laboratories, Christchurch, New Zealand, for further confirmation. Complete blood count was performed on the day of the patient’s visit using automatic blood cell counter (PCE-210, Erma Particle Counter). Whole blood samples (stored at −70°C) were tested by real-time PCR for R. typhi at Canterbury Health Laboratories using an assay described elsewhere [7].

Nutritional Status

Weight for age Z-scores were calculated for each subject (EpiInfo 2002). Moderate or severe malnutrition was defined as a Z-score <−2 and severe malnutrition was defined as a Z-score <−3.

Statistical Analysis

Data from patients with enteric fever were compared with other patients using the chi-square test or Fisher exact test for dichotomous and ordinal variables, and 2-sided Wilcoxon rank sum test and the Student t test for continuous variables. We used multivariable logistic regression analysis to further evaluate variables associated with enteric fever. Enteric fever was the outcome variable in the final model; other variables were those associated with the outcome with p<0.1 on bivariable analysis. Likelihood ratio tests were used to compare models with and without interaction terms. Collinearity was tested by a correlation matrix. Data were analyzed using Stata version 11.0 (StataCorp, College Station, TX).

Ethics Statement

Ethics approval to conduct this study was obtained from Nepal Health Research Council (Ref. no. 686, 46) and Oxford Tropical Research Ethics Committee (OXTREC 026-04, 032-06).

Results

During the two study periods, 1084 (845 in summer and 239 in winter) febrile children less than 15 years of age were enrolled (Table 1). Of the total, 649 (60%) were male and 227 (21%) had reported taking antibiotics within 48 hours before presentation. Over the entire study period, upper respiratory tract infection and enteric fever were the most common initial clinical diagnoses. Enteric fever was the most common initial diagnosis in summer and respiratory tract infection in the winter.
Table 1

Clinical characteristics of febrile children presenting to the Pediatric Outpatient Department at Patan Hospital, Nepal, during the summer and winter study periods.

CharacteristicsSummer (n = 845)Winter (n = 239)
Age (years), median (range)4 (2 months–14 years)4 (2 months–14 years)
Male502 (59%)147 (62%)
Recruitment rate (no./day)104
Duration of fever (days), median (range)3 (<1–30)2 (<1–9)
Temperature at presentation (°C), median (range)38.3 (38–42)38.5 (38–40)
Antibiotic use reported within 48 hours before presentation186 (22%)41 (17%)
Clinical diagnosis at presentation
Enteric fever311 (37%)23 (10%)
Lower respiratory tract infection125 (15%)25 (10%)
Upper respiratory tract infection216 (26%)159 (67%)
Acute gastroenteritis/Dysentery24 (3%)4 (2%)
Urinary tract infection28 (3%)2 (1%)
Viral fever (without obvious focus of infection)106 (13%)16 (7%)

Diagnostic Testing

Whole blood for culture was received from all the enrolled patients and the average blood volume drawn was 2.3 mL. Only 4% had blood volume <1 mL. Only five (0.5%) of the blood cultures yielded an isolate thought to be a contaminant. Whole blood specimens were available from all of the patients for testing by PCR for R. typhi. As presented in Table 2, putative etiological agents for fever were identified in 164 (15%) patients. Salmonella enterica serovar Typhi (S. Typhi) was the most common organism isolated from blood during both seasons. The median age of patients for bacteremia differed by pathogen (Table 3). The median age for S. Typhi, S. Paratyphi A and R. typhi infection was above five years and for S. pneumoniae was below five years.
Table 2

Etiological agents identified in febrile children presenting to the Pediatric Outpatient Department at Patan Hospital, Nepal, during the summer and winter study periods.

Bacterial pathogenSummer (n = 845)Winter (n = 239)
Bloodstream isolates (Blood culture) 131 (16%)16 (7%)
 Salmonella enterica serovar Typhi95 (11%)12 (5%)
 Salmonella enterica serovar Paratyphi A29 (3%)1 (0.4%)
 Salmonella enterica serovar Typhimurium2 (0.2%)0 (0%)
 Streptococcus pneumoniae 3 (0.4%)3 (1%)
 Haemophilus influenzae type b1 (0.1%)0 (0%)
 Escherichia coli 1 (0.1%)0 (0%)
PCR
 Rickettsia typhi 17 (2%)5 (2%)

4 R. typhi PCR positive patients had S. Typhi and 1 had S. Paratyphi A in blood culture.

Table 3

Pathogens responsible for blood stream infections according to age group*.

Pathogen IsolatesAge Groups (Total patients = 1084)Median age (IQR)
2 - <6 mo (n = 20)6 mo - <1 yr (n = 77)1 - <5 yr (n = 503)5–14 yr (n = 484)
Gram-positive
 Streptococcus pneumoniae 6 (4)004 (9)2 (2)41 (31–67)
Gram-negative
 Salmonella enterica serotype Typhi107 (73)01 (33)35 (74)71 (73)76 (45–118)
 Salmonella enterica serotype Paratyphi A30 (20)006 (13)24 (25)117 (71–139)
 Salmonella enterica serotype Typhimurium2 (1)01 (33)1 (2)016 (12–19)
 Haemophilus influenzae type b1 (1)001 (2)032
Escherichia coli 1 (1)01 (33)0010
Total bacterial isolates by blood culture 147 (100)03479779 (45–121)
Rickettsia (PCR)
 Rickettsia typhi 221161478 (30–112)
Total microbiological diagnosis 169†† 145311178 (44–121)

Data are no. (%) or no. unless stated otherwise. Percents shown for column totals only for bacterial isolates by blood culture.

Pathogens isolated by blood culture unless indicated otherwise.

Median age in months.

4 patients with S. Typhi and 1 patient with S. Paratyphi A were PCR positive for R. typhi.

4 R. typhi PCR positive patients had S. Typhi and 1 had S. Paratyphi A in blood culture. Data are no. (%) or no. unless stated otherwise. Percents shown for column totals only for bacterial isolates by blood culture. Pathogens isolated by blood culture unless indicated otherwise. Median age in months. 4 patients with S. Typhi and 1 patient with S. Paratyphi A were PCR positive for R. typhi. Twenty-two (2%) patients had positive R. typhi PCR results. Five patients in summer, who were positive for R. typhi PCR, also had bacterial isolates in blood culture. Four of these patients had S. Typhi and one had S. Paratyphi A. There were no dual etiological diagnoses in winter.

Antimicrobial Susceptibility Testing

Among the 107 isolates of S. Typhi, 60 (56%) were resistant to nalidixic acid and, of these, only 3 showed intermediate resistance to ciprofloxacin. Among the 30 S. Paratyphi A isolates, 27 (90%) were resistant to nalidixic acid and, of these, 3 showed intermediate resistance to ciprofloxacin. One of the two S. Typhimurium isolates showed resistance to nalidixic acid and gentamicin. None of the six S. pneumoniae was resistant to penicillin but three were resistant to cotrimoxazole and one showed intermediate resistance to chloramphenicol. The single H. influenzae type b isolate was resistant to amoxicillin.

Clinical Associations

Enteric fever

Out of the total 1084 patients, 137 (13%) had culture-confirmed enteric fever. Among 600 total children under five years of age, 42 (7%) had culture-confirmed enteric fever (36 positive for S. Typhi and 6 positive for S. Paratyphi A). Whereas among 484 total children ≥5 years of age, 95 (20%) had culture-confirmed enteric fever (71 positive for S. Typhi and 24 positive for S. Paratyphi A). Compared with all the other patients in the cohort, the patients with culture-confirmed enteric fever were more likely to be older, have fever for more than three days at presentation, present in the summer, be moderately or severely malnourished, and were more likely to have headache, abdominal pain, diarrhea and splenomegaly (Table 4). These children were also less likely to present with cough or rhinorrhea. No significant differences were found between culture positive typhoid and paratyphoid fever cases.
Table 4

Demographic, clinical and laboratory features of patients with culture-confirmed enteric fever and their comparison with all the other patients in the cohort*.

Variable S. Typhi/S. Paratyphi A bacteremia (n = 137)Others (n = 947) p value
Demographics
Age, months, median (range)81.3 (10.9–167.8)48.4 (2.6–208)<0.001
Male sex74 (54)575 (61)0.14
Summer Season124 (91)721 (76)<0.001
Duration of fever, days, median (range)4 (1–22)3 (0–30)<0.001
Duration of fever >3 days76 (55)309 (33)<0.001
Antibiotics taken within 48 hours before presentation41/125 (33)186/762 (24)0.05
Symptoms
Cough55/137 (40)613/946 (65)<0.001
Shortness of breath0/137 (0)7/944 (0.7)0.31
Nausea/vomiting49/137 (36)274/947 (29)0.10
Diarrhea21/137 (15)72/944 (8)0.003
Abdominal pain76/131 (58)311/766 (41)<0.001
Headache92/130 (71)355/710 (50)<0.001
Joint pain1/130 (0.8)10/703 (1)0.55
Muscle pain0/130 (0)23/702 (3)0.04
Baseline Observations
Temperature, °C, mean (SD)38.8 (0.7)38.3 (1.3)0.01
Pulse rate (per minute), mean (SD)121 (15)124 (19)0.05
Respiratory rate, breaths per minute, mean (SD)29 (9)32 (11)0.004
Hepatomegaly16/137 (12)72/940 (8)0.11
Splenomegaly21/137 (15)77/940 (8)0.007
Rhinorrhea28/137 (20)427/943 (45)<0.001
Moderate or severe malnutrition46/110 (42)242/784 (31)0.02
Laboratory findings
Hematocrit, %, mean (SD)36 (4.5)35.6 (4.9)0.38
Leukocyte count, total count/mm3, median (IQR)7250 (6000–9050)9750 (7100–13600)<0.001
Leukocyte count >11000/mm3 17/136 (13)368/947 (39)<0.001

Data are no. (%) unless stated otherwise. SD, standard deviation; IQR, interquartile range.

Data are no. (%) unless stated otherwise. SD, standard deviation; IQR, interquartile range. On multivariable analysis, culture-confirmed enteric fever was only independently associated with increasing age, diarrhea, duration of fever more than three days, and inversely associated with cough, leukocytosis, and (in winter only) rhinorrhea (Table 5).
Table 5

Associations with S. Typhi/S. Paratyphi A bacteremia on multivariable analysis.

VariableOR95% CI p value
Age group<1 year1.0
1–5 years5.490.73 to 41.300.10
>5 years10.941.46 to 81.850.02
Cough0.480.30 to 0.750.001
Diarrhea2.221.18 to 4.170.01
Duration of fever >3 days1.641.04 to 2.570.03
Splenomegaly1.050.55 to 2.010.88
Rhinorrheasummer0.700.39 to 1.270.24
Winter0.130.03 to 0.640.01
WBC >11,000/mm3 0.330.18 to 0.59<0.001
Moderate/severe malnutrition1.360.86 to 2.140.18
Among blood culture positive patients, those who had leukocyte count <5000/mm3 were all positive for S. Typhi or S. Paratyphi A. Among the culture-confirmed enteric fever patients, fifteen (11%) had leukocyte count ≤5000/mm3 and four (3%) patients had a leukocyte count ≥20,000/mm3 with ≥50% polymorphonuclear cells; all these four patients were below five years of age. Nine (2%) of 375 patients who were presumed to have upper respiratory tract infection at presentation, had S. Typhi or S. Paratyphi A in their blood cultures. Among the patients with duration of fever with rhinorrhea more than five days, 12/46 (26%) had culture-confirmed enteric fever.

Murine typhus

There were 22 patients (2%) who were PCR positive for R. typhi. Of these, 13 (59%) were male and the median age was 6.4 years. Enteric fever was the most common clinical diagnosis (45%) at presentation for these patients. Compared with all the other patients in the cohort, these patients were more likely to present with nausea or vomiting (50% versus 29.4%; p = 0.04) and diarrhea (31.8% versus 8.1%; p<0.001), and were less likely to present with cough (36.4% vs. 62.2%, p = 0.01). No demographic, clinical and laboratory features distinguished these patients from patients with culture-confirmed enteric fever. None of these patients presented with rash.

Pneumonia

Of the 192 (18%) patients with pneumonia as a final diagnosis, only seven (4%) had positive blood cultures (six with S. pneumoniae and one with H. influenzae type b). All of these seven patients had neutrophil count >11,000/mm3 and presented with duration of illness of less than five days.

Discussion

To our knowledge, this is the first study in the Indian subcontinent to examine bloodstream infections among children up to 14 years of age presenting to an outpatient clinic, the only inclusion criteria for whom was documented fever ≥38°C. In our study, all febrile children were studied rather than a subset of more severely ill children. Every child enrolled had a blood culture performed irrespective of severity of disease. Studies conducted in South Asia that included children either concentrated on pneumonia or acute respiratory infections [15], [16], [17], included more severe patients [18], [19], collected data based on blood cultures received in the laboratory [20], [21], or focused on patients diagnosed with specific disease syndromes such as typhoid fever [22], [23]. Two studies [24], [25] which looked at typhoid and paratyphoid bacteremia are similar to our study; however, they were community-based studies and only the bacteremia rate from patients under five years from one of the two studies can be compared with our results (see below). Even though we excluded patients severe enough to be hospitalized, some 15% of children with febrile illness who were managed in the outpatient setting in our study had documented bacteremia. This was largely driven by the burden of enteric fever, but we also documented the presence of invasive pneumococcal and H. influenzae type b infections. This study also confirms that murine typhus, previously unrecognized as an important pathogen among children in Nepal, is endemic in Kathmandu Valley. We found that distinguishing between enteric fever and murine typhus is clinically difficult. Enteric fever is an important cause of illness and death in south-central and south-east Asia, particularly among children and adolescents [26]. In this study, S. Typhi and S. Paratyphi A were the most common bloodstream isolates, comparable to the results found in the Nepal study in adults [4]. Culture-confirmed enteric fever was also relatively common in children aged less than five years, which has been noted in other Asian studies [20], [25], [27]. In children less than five years, S. Typhi isolation rate was 6% compared to 4.4% in the study conducted in Bangladesh [24], which had similar inclusion criteria to our study but only for children under five years. However, S. Paratyphi A isolation rate in our study was 1% compared to 0.2% in the Bangladesh study. During the last decade, salmonella bacteremia in our hospital patients has more than doubled, and S. Paratyphi A as a proportion of all salmonella isolates has risen significantly [28]. The latter has been attributed to the emergence of a single clone of S. Paratyphi A in South Asia [29]. In our study, the clinical presentations of S. Typhi and S. Paratyphi A infections were similar. This is consistent with studies from Indonesia [30] and among adult Nepalis [31] that showed these two infections were clinically indistinguishable and had equal severity. Compared with other patients in the study, children with culture-confirmed enteric fever were more likely to be older, have diarrhea, and have a more prolonged duration of fever, and were less likely to have a raised leukocyte count or cough. While the odds of enteric fever were considerably reduced in children with rhinorrhea during the winter period, one-quarter of all patients with fever and rhinorrhea lasting more than five days were culture-positive for S. Typhi or S. Paratyphi A. This finding is clinically important as standard practice here has been to avoid blood cultures in outpatients with obvious upper respiratory infections. Nalidixic acid resistance was more common in S. Paratyphi A isolates compared with S. Typhi (90% vs 56%). This is in concordance with other studies undertaken in our hospital [31] and in India [32]. Nalidixic acid resistance is a marker of reduced susceptibility to the fluoroquinolone group [33], [34], [35], [36] which may be associated with increased clinical virulence [37] and treatment failure [38], [39], [40]. Widespread use of ciprofloxacin/ofloxacin in Nepal may have driven this increase in fluoroquinolone resistance and alternative approaches to management may be needed, such as azithromycin or gatifloxacin [41]. We did not have any multidrug-resistant salmonella in our study. Nevertheless, there have been reports of extended-spectrum β-lactamase-producing S. Typhi in Asia [42], [43] and from travelers returning from Asia [44], [45]. Multidrug-resistant extended-spectrum β-lactamase-producing S. Paratyphi A has also been reported from blood isolates in Nepal [46], leading to further concerns about optimal management of the condition where third generation cephalosporins have been widely used for hospitalized cases. Effective typhoid vaccines [47], [48] should be considered for programmatic use in Kathmandu Valley, and paratyphoid vaccines are urgently needed following the emergence of S. Paratyphi A as a major cause of enteric fever in the region [28], [46]. Health education, adequate sanitation and the use of chlorinated water will greatly help to reduce the public health burden both now and in the future, but the scale of the problem means that this cannot be resolved rapidly in Kathmandu Valley and immunization is the only intervention which could have a rapid impact. There is growing interest in the importance of murine typhus in Nepal following the findings of recent studies in adults [3], [7] and given the frequent contact between humans and rodents in urban areas. Rats and other rodents are the natural reservoirs for R. typhi, with the rat flea being the transmission vector to humans. Since R. typhi antibodies can persist for several months to years following infection [49] and serological detection is non-specific and cross-reactive [4], [50], (and in the absence of convalescent sera), we tested blood samples by real-time PCR assays for R. typhi using a recently developed sensitive and specific method [51]. We detected R. typhi DNA in the blood from 22 (2%) patients, with a similar prevalence across both seasons. This contrasts with the earlier adult study in Kathmandu Valley that showed an overall prevalence of 7% and winter predominance [7]. This adult study had similar patient inclusion criteria to ours (although hospitalized patients were included) and used real-time PCR for R. typhi detection. The other serological study conducted in Nepal [3] among a subset of febrile patients used indirect microimmunofluorescence assay for detection of antibodies to R. typhi; this study showed that 26% of their patients were positive for R. typhi IgM antibody. Five of our patients who were positive for R. typhi also had positive blood cultures for other bacteria making the significance of the R. typhi results uncertain. The collective evidence of recent studies suggests that murine typhus is endemic in Kathmandu Valley, but further focused studies are needed to more precisely determine the burden of disease in children and the clinical significance of a positive PCR in suitable controls. This is especially important given its clinical similarity with enteric fever as this pediatric study and the adult study [7] emphasize the similar clinical features of blood culture positive enteric fever and murine typhus. The absence of rash has been consistently reported in murine typhus from Nepal [7]. Murine typhus should be considered as an alternative diagnosis in patients suspected with enteric fever in Nepal, especially in those not responding to first-line antimicrobial drug therapy to enteric fever [7]. This study has several limitations. For practical reasons we could only conduct the study during two brief periods to capture the seasonal variation of infectious diseases in the Valley. Consequently, we lack data over a complete year or over multiple years to account for annual variation in disease rates. We did not follow-up patients for the study purpose and, therefore, have no data on outcomes once they were sent home from the clinic. We did not test for HIV infection given the low seroprevalence among children admitted with febrile illness in Nepal. Of 485 serum samples tested from admitted febrile children around the same time, only one (0.2%) was positive for HIV antibodies [1]. Other possible pathogens detected by serological diagnoses such as Leptospira spp., Orientia tsutsugamushi, dengue viruses, as shown in the adult population [3], [4], were not included in this study because of limited resources and blood volumes. However, this study has highlighted the burden of enteric fever among children in Kathmandu Valley, including children considered well enough to be managed in an outpatient/primary care setting. Sentinel studies like this in resource poor settings can define the burden, pattern and treatment of infectious diseases and alter healthcare delivery. However, since the spectrum of pathogens, incidence of diseases and antimicrobial susceptibility change over time, the data should be monitored continuously to allow an appropriate clinical response and healthcare planning. The data show that immunization programmes against invasive bacterial disease could improve the health of children in Kathmandu Valley and that there is a pressing need for effective vaccines against the agents of enteric fever.
  48 in total

1.  Salmonella enterica serovar Typhi strain producing extended-spectrum β-lactamases in Dhaka, Bangladesh.

Authors:  Dilruba Ahmed; Ashfaqul Hoque; Razib Mazumder; Kamrun Nahar; Nazrul Islam; Shawkat Ali Gazi; M Anowar Hossain
Journal:  J Med Microbiol       Date:  2012-03-22       Impact factor: 2.472

2.  Diagnosis and management of febrile children using the WHO/UNICEF guidelines for IMCI in Dhaka, Bangladesh.

Authors:  S H Factor; J A Schillinger; H D Kalter; S Saha; H Begum; A Hossain; M Hossain; V Dewitt; M Hanif; N Khan; B Perkins; R E Black; B Schwartz
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

3.  Typhoid fever in Bangladesh: implications for vaccination policy.

Authors:  S K Saha; A H Baqui; M Hanif; G L Darmstadt; M Ruhulamin; T Nagatake; M Santosham; R E Black
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

4.  Diagnoses of acute lower respiratory tract infections in children in Rawalpindi and Islamabad, Pakistan.

Authors:  A Ghafoor; N K Nomani; Z Ishaq; S Z Zaidi; F Anwar; M I Burney; A W Qureshi; S A Ahmad
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

5.  Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.

Authors:  K Renuka; A Kapil; S K Kabra; N Wig; B K Das; V V S P Prasad; R Chaudhry; P Seth
Journal:  Microb Drug Resist       Date:  2004       Impact factor: 3.431

Review 6.  The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.

Authors:  Christopher M Parry
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-07       Impact factor: 2.184

7.  Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi.

Authors:  Priscilla Rupali; O C Abraham; Mary V Jesudason; T Jacob John; Anand Zachariah; Subramanian Sivaram; Dilip Mathai
Journal:  Diagn Microbiol Infect Dis       Date:  2004-05       Impact factor: 2.803

8.  Use of a sensitive microplate enzyme-linked immunosorbent assay in a retrospective serological analysis of a laboratory population at risk to infection with typhus group rickettsiae.

Authors:  S Halle; G A Dasch
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

9.  The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal.

Authors:  David R Murdoch; Christopher W Woods; Mark D Zimmerman; Peter M Dull; Ram Hari Belbase; Andrew J Keenan; Robert Mcnair Scott; Buddha Basnyat; Lennox K Archibald; L Barth Reller
Journal:  Am J Trop Med Hyg       Date:  2004-06       Impact factor: 2.345

10.  Emerging rickettsial infections in Sri Lanka: the pattern in the hilly Central Province.

Authors:  S A M Kularatne; J S Edirisingha; I B Gawarammana; H Urakami; M Chenchittikul; I Kaiho
Journal:  Trop Med Int Health       Date:  2003-09       Impact factor: 2.622

View more
  17 in total

1.  Pathogen genomic surveillance of typhoidal Salmonella infection in adults and children reveals no association between clinical outcomes and infecting genotypes.

Authors:  Carl D Britto; Sitarah Mathias; Ashish Bosco; Zoe A Dyson; Gordon Dougan; Savitha Raveendran; V L Abin; Sanju Jose; Savitha Nagaraj; Kathryn E Holt; Andrew J Pollard
Journal:  Trop Med Health       Date:  2020-07-13

2.  Evaluation of an electricity-free, culture-based approach for detecting typhoidal Salmonella bacteremia during enteric fever in a high burden, resource-limited setting.

Authors:  Jason R Andrews; Krishna G Prajapati; Elizabeth Eypper; Poojan Shrestha; Mila Shakya; Kamal R Pathak; Niva Joshi; Priyanka Tiwari; Manisha Risal; Samir Koirala; Abhilasha Karkey; Sabina Dongol; Shawn Wen; Amy B Smith; Duncan Maru; Buddha Basnyat; Stephen Baker; Jeremy Farrar; Edward T Ryan; Elizabeth Hohmann; Amit Arjyal
Journal:  PLoS Negl Trop Dis       Date:  2013-06-27

3.  Health problems in travellers to Nepal visiting CIWEC clinic in Kathmandu - A GeoSentinel analysis.

Authors:  Prativa Pandey; Keun Lee; Bhawana Amatya; Kristina M Angelo; David R Shlim; Holly Murphy
Journal:  Travel Med Infect Dis       Date:  2021-02-24       Impact factor: 20.441

4.  Childhood septicemia in Nepal: documenting the bacterial etiology and its susceptibility to antibiotics.

Authors:  Shamshul Ansari; Hari Prasad Nepal; Rajendra Gautam; Sony Shrestha; Puja Neopane; Brihaspati Rimal; Fuleshwar Mandal; Safiur Rahman Ansari; Moti Lal Chapagain
Journal:  Int J Microbiol       Date:  2014-12-25

5.  A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital.

Authors:  Raphaël M Zellweger; Buddha Basnyat; Poojan Shrestha; Krishna G Prajapati; Sabina Dongol; Paban K Sharma; Samir Koirala; Thomas C Darton; Christiane Dolecek; Corinne N Thompson; Guy E Thwaites; Stephen G Baker; Abhilasha Karkey
Journal:  PLoS Negl Trop Dis       Date:  2017-11-27

Review 6.  An Appraisal of the Clinical Features of Pediatric Enteric Fever: Systematic Review and Meta-analysis of the Age-Stratified Disease Occurrence.

Authors:  Carl Britto; Andrew J Pollard; Merryn Voysey; Christoph J Blohmke
Journal:  Clin Infect Dis       Date:  2017-06-01       Impact factor: 9.079

7.  Evaluating the Trends of Bloodstream Infections among Pediatric and Adult Patients at a Teaching Hospital of Kathmandu, Nepal: Role of Drug Resistant Pathogens.

Authors:  Narayan Prasad Parajuli; Hridaya Parajuli; Roshan Pandit; Jyotsna Shakya; Puspa Raj Khanal
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-04-06       Impact factor: 2.471

8.  Laboratory and molecular surveillance of paediatric typhoidal Salmonella in Nepal: Antimicrobial resistance and implications for vaccine policy.

Authors:  Carl D Britto; Zoe A Dyson; Sebastian Duchene; Michael J Carter; Meeru Gurung; Dominic F Kelly; David R Murdoch; Imran Ansari; Stephen Thorson; Shrijana Shrestha; Neelam Adhikari; Gordon Dougan; Kathryn E Holt; Andrew J Pollard
Journal:  PLoS Negl Trop Dis       Date:  2018-04-23

9.  An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.

Authors:  Claire S Waddington; Thomas C Darton; Claire Jones; Kathryn Haworth; Anna Peters; Tessa John; Ben A V Thompson; Simon A Kerridge; Robert A Kingsley; Liqing Zhou; Kathryn E Holt; Ly-Mee Yu; Stephen Lockhart; Jeremy J Farrar; Marcelo B Sztein; Gordon Dougan; Brian Angus; Myron M Levine; Andrew J Pollard
Journal:  Clin Infect Dis       Date:  2014-02-10       Impact factor: 9.079

10.  Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial.

Authors:  Celina Jin; Malick M Gibani; Maria Moore; Helene B Juel; Elizabeth Jones; James Meiring; Victoria Harris; Jonathan Gardner; Anna Nebykova; Simon A Kerridge; Jennifer Hill; Helena Thomaides-Brears; Christoph J Blohmke; Ly-Mee Yu; Brian Angus; Andrew J Pollard
Journal:  Lancet       Date:  2017-09-28       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.